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ABSTRACT
Yeast artificial chromosomes (YACs) represent the
latest generation of vectors which have the great
advantage of large insert size. The introduction of YACs
into mammalian cells and organisms has become an
important goal, since it offers the potential to study the
control of large and complex transcription units and
identify genes by complementation. Microinjection into
the nucleus is the most direct and efficient way of
delivering YAC DNA into cells, but requires the
purification of the YAC from the remaining yeast
chromosomes. Here we describe a detailed method for
the isolation of pure, intact and highly concentrated
YAC DNA. As a model system the murine tyrosinase
gene was chosen and four YACs covering this locus
were isolated. Introduction by homologous
recombination in yeast of sequences permitting YAC
amplification greatly facilitated the isolation of YAC
DNA at high concentrations. YAC DNA stabilized in a
salt and polyamine containing buffer did not
compromise the survival of microinjected oocytes and
was suitable for the generation of transgenic mice.
Applications and benefits of this technique will be
discussed.
INTRODUCTION
Yeast artificial chromosomes (YACs) (1) have proven to be a
powerful tool in cloning large fragments of DNA and in genome
analysis. Unique amongst cloning vectors they offer the possibility
of cloning and stably maintaining in excess of 1000kb of DNA
in the yeast host Saccharomyces cerevisiae. Therefore, they can
be used to close the existing gap between genetic and physical
maps and to clone complex transcriptional units and gene clusters
on single fragments of DNA. Furthermore, YACs are easily
manipulated and modified owing to the highly active
recombination system in yeast in which homologous events
greatly predominate.
Given these potentials, the introduction of YACs into
mammalian cells and the germline of the mouse has been a major
goal. By overcoming the size constraints imposed by other
vectors, YACs will allow the function and regulation of genes
and gene clusters to be studied in conditions closely approaching
their natural context. YACs have been introduced into
mammalian cell lines, including embryonic stem (ES) cells, by
spheroblast fusion (2-5) , lipofection (6), calcium phosphate
coprecipitation (7), and electroporation (8). In these cases,
however, the entire yeast genome was introduced in addition to
the YAC DNA. Although mice have been produced from ES
cells containing the entire yeast genome without apparent adverse
effects (5), the vast amount of additional genetic material is
undesirable and a potential source of insertional mutagenesis.
Isolated YAC DNA has been introduced into somatic cells (9)
and ES cells (10,11) by lipofection, but the number of clones
with integrated YAC DNA was relatively low. The manipulated
ES cells were able to contribute to the germline of mice.
The most direct and efficient way to deliver DNA into cells
is microinjection into the nucleus, and YAC DNA has been
introduced into cultured cells (12) and the germline of mice
(13,14) by this means. For the successful application of this
technique to the generation of transgenic mice, the DNA must
be intact, sufficiently concentrated to ensure a high frequency
of integration and pure enough to allow survival of the oocytes.
In addition, the DNA should be stabilized to prevent shearing
of the large molecules during purification and passage through
the microinjection needle. The large size, linearity and single
copy nature of YACs make preparation of clean, intact and
concentrated DNA difficult. This difficulty could be overcome
with an amplifiable YAC vector (15) based on a conditional
centromere (16), which allows up to 25 fold amplification of the
YAC in yeast. After such amplification, YAC DNA can account
for as much as 50% of the entire yeast DNA. Unfortunately,
the YAC libraries presently available have not been constructed
with this type of amplifiable vector. Here we describe the
modification of a YAC covering the tyrosinase locus to allow
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its amplification and a protocol for the isolation of highly
concentrated, pure and stabilized YAC DNA, which we have
been able to use for the generation of transgenic mice (14).
MATERIALS AND METHODS
Isolation and characterization of YACs
The tyrosinase cDNA clone pmcTyrlO2 (17) was used to screen
a YAC library of C3H mouse DNA (18) by colony filter
hybridization. Four independent YACs were isolated and
designated Tyrl to Tyr4. In addition to pmcTyrlO2, four mouse
genomic probes (Figure 1) were used to characterize the YACs:
Tyrl4.E6 is a 3.6kb £coRI fragment from \gTYR14 (17);
JLE1.7, ILE4.8 and JLE1.2 have been described elsewhere (19).
Radioactively labelled mouse DNA was used to detect all mouse
DNA containing restriction fragments of the YACs. Probes
specific for the left and right YAC vector arm were generated
by digestion of pBR322 with £coRI and PvuU; the 2.3kb and
2.0kb fragments were used for the long and short arm,
respectively. Agarose plugs of YAC DNA for mapping were
prepared essentially as described (20) and contained 1X108 cells
per 80/tl plug. Methods for digestion, pulsed field gel
electrophoresis (PFGE), blotting, radioactive probe synthesis and
hybridization have previously been described (19)
Media and yeast transformation
YAC Tyrl was modified by spheroblast transformation
(essentially as described in 21) of the corresponding yeast strain
with 5/tg of BamW linearized pFRAT3' (Figure 2). pFRAT3'
was constructed by cloning a 5kb EcoKUBamYlI fragment from
XgTYR4 (17) which contains exon 5 of the tyrosinase gene into
the 10kb fragment of EcoM/Bamm digested Y-RC16 (13).
Transformants were selected on synthetic medium (lacking uracil)
containing 0.8mg/ml thymidine, 50/tg/ml methotrexate, 2mg/ml
sulphanilamide, 2% agar and 1M sorbitol. The appropriately
modified YAC was called YRT2. Transformation of YRT2 into
S.cerevisiae strain CGY2516 (MATa GAL+ ura3-52 trpl-A63
Ieu2-Al lys2-A202 his3-A200; ATCC # 74013) was carried out
after isolation of YAC DNA from a preparative pulsed field
electrophoresis gel (running conditions as below) followed by
agarase (Gelase, Epicentre) digestion. Transformants were
selected on synthetic medium (22) lacking uracil. Amplification
of the YAC was performed as described previously (13,15).
Isolation of YAC DNA and microinjection into mouse oocytes
200ml of selective medium lacking uracil were inoculated with
200/tl of amplified YRT2 yeast culture (grown as described in
refs. 13,15) and shaken for two days at 30°C. Cells were
collected by centrifugation at 3000rpm for 5min (Sorvall RT
6000B), washed once in double destilled water and once in SCE
(1M sorbitol, 0.1M Na3citrate, lOmM EDTA, pH7.0) and
collected in a single tube. After careful removal of the supernatant
a few drops of SCE were added to the pellet sufficient to take
up die cells in a thick suspension. The same volume of preheated
(50°C) 1 % low melting point (LMP) agarose (BRL Ultrapure)
dissolved in SCE containing 20mg/ml Novozyme 234
(NovoBiolabs) was added and the mixture quickly dispensed into
Pharmacia plug formers (80/il/plug) sitting on ice. After lOmin
the plugs were transfered to SCE supplemented widi lOmM DTT,
incubated for 3h at 37°C and then to a 1% lithium dodecyl
sulphate/lOOmM EDTA solution for 16h at 50°C. After removing
the detergent by several washings in TE (lOmM Tris:HCl, lmM
EDTA, pH8.0) plugs were stored at 4°C in 0.5M EDTA pH8.0
until use.
For purification of YAC DNA, plugs equilibrated in TE were
loaded next to one another in a 4cm slot of a 20 x 20cm 1 % LMP
agarose (Seaplaque, FMC) 0.25 XTAE gel (TAE = 40mM
Tris:acetate, lmM EDTA). The plugs were positioned vertically
to occupy the height of the gel. PFGE running conditions
optimized for the 250kb YAC were 250V for 1 Oh with a switch
interval of 9s, followed by 6h with a 15s switch. After staining
marker lanes on either side with ethidium bromide, a gel slice
containing YAC DNA was excised from the preparative lane,
and yeast chromosome DNA containing slices above and below
the YAC band were removed to serve as marker lanes for the
second gel run. The gel slices were equilibrated in lxTAE,
positioned on a minigel tray with the YAC slice in the middle
and a 4% LMP agarose (Nusieve, FMC) 1 XTAE gel cast around
them. A second gel run (3-5h, 4V/cm) was performed, with
buffer circulation, at a 90° angle to the PFGE run. The two
marker lanes were stained to localize the DNA, and the
concentrated material was excised from the corresponding
position of the YAC DNA lane. The gel slice was equilibrated
in 1 XTAE, lOOmM NaCl, 30/M spermine, 70/tM spermidine,
melted at 68°C for lOmin, and digested with 4U Gelase
(Epicentre) per lOOmg of gel slice for 2h. The resulting DNA
solution was dialysed for 2h on a floating dialysis membrane
(Millipore, pore size 0.05/tm) against microinjection buffer:
lOmM Tris:HCl, pH7.5, O.lmM EDTA, lOOmM NaCl, 30/tM
spermine, 70/tM spermidine. The concentration of purified DNA
was estimated on a 0.8% agarose minigel using X DNA of known
concentration as a standard.
DNA was microinjected into the pronuclei of NMRI/Han
fertilized oocytes following standard techniques (23). Oocytes
surviving manipulation were transferred to NMRI/Han foster
mothers. Transgenic mice were identified on Southern blots of
Hindm digested tail biopsy DNA hybridized with randomly
primed 4.5 and 5.4kb Hindm fragments of Y-RC16 (13).
RESULTS AND DISCUSSION
Isolation and characterization of YACs covering the mouse
tyrosinase locus
The mouse tyrosinase gene was chosen to develop procedures
for the creation of transgenic mice with YAC DNA because of
the large size of the gene (80kb, reference 17), and because
tyrosinase expression determines an obvious phenotype in mice
(14,24-26). Four YACs (Tyrl to Tyr4) containing the tyrosinase
gene were isolated from a YAC library of C3H DNA (18) after
screening with a full lengdi tyrosinase cDNA probe (17). The
YACs were characterized by hybridization ofSmal digests with
mouse DNA, the tyrosinase cDNA and four genomic probes
spanning the tyrosinase locus (Figure 1 and data not shown). In
addition, probes for the vector arms were used to identify
fragments at the ends of the YACs. The restricition maps of
YACs Tyrl and Tyr2 were found to be in good agreement with
a long-range map of Smal sites established around the mouse
tyrosinase gene (c0* allele, G.K., unpublished results). The only
significant discrepancy between the YACs and the long range
map concerned the Smal fragments at the 5' end of the tyrosinase
gene: 75kb on the YACs, 60kb detected by Tyrl4:E6 in cch/cch
DNA, and 58kb on die c°h allele cloned in X libraries. This
difference might indicate an insertion in die C3H DNA carried
on die YACs, and might account for an EcoRl site polymorphism
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Figure 1. Characterization of YACs encompassing the tyrosinase locus. The upper
line represents a physical map of Smal sites around the mouse tyrosinase (c) locus
(the <?h allele, details available on request). Proximal and distal indicate
orientation with respect to the centromere of mouse chromosome 7. Regions cloned
in X phages (11,19,34) are depicted as thick lines below the chromosome. The
position of probes used to analyse of the tyrosinase gene YACs are indicated.
Below, the physical maps of the four YACs (Tyrl, Tyr2, Tyr3 and Tyr4) isolated
with the tyrosinase cDNA are shown. YAC vector sequences are given as open
boxes. Circles represent the centromeres on the long vector arms. Broken lines
are regions of the YACs which have not been mapped in detail and might
correspond to coligations or rearrangements of the inserts. The bar above the
55kb Smal fragment within the tyrosinase region of the YACs indicates a restriction
fragment length variant between the ch and the C3H allele.
identified previously (14). Tyr3 was suspected to have undergone
a rearrangement at its distal end, since YACs of 500 and 450kb
were detected by hybridization in the original isolate, and the
YAC long arm probe detected two fragments in Smal digests.
Tyr4 contained few Smal fragments in common with the other
YACs, which implied that it extended the furthest distally.
However, the lack of information of Smal sites distal to the
tyrosinase gene precluded its further characterization, and analysis
with other enzymes suggested that Tyr4 might be a chimaeric
clone (A.S., unpublished results). All four YACs cover the entire
tyrosinase gene as judged by hybridization of the cDNA probe
to 75kb and 130kb Smal fragments containing the 5' and 3' halves
of the tyrosinase gene, respectively, with the exception that in
Tyr4 the 130kb Smal fragment was replaced by a 70kb fragment
at one end of the YAC (Figure 1).
The tyrosinase YACs map to the centre of the region on
chromosome 7 defined by a series of radiation induced deletions
that comprise the albino-deletion complex. Many albino deletions
have recessive lethal phenotypes and genetic complementation
tests have identified at least six loci which are required for normal
mouse development (reviewed in 27). In addition to the present
studies, the tyrosinase YACs will provide a useful resource for
the positional cloning approaches which have been initiated for
several of these loci (28).
Modification of YAC Tyrl and isolation of YAC DNA
To obtain higher yields of YACs for purification of DNA, we
introduced an amplification system (15) into Tyrl. The vector
arm containing the centromere maps 3' to the tyrosinase gene
in Tyrl. A fragmentation vector, pFRAT3' (Figure 2), was
designed which consists of 5kb sequences homologous to the 3'
end of the tyrosinase gene and the centromere containing arm
of Y-RC16, an amplifiable YAC vector (13). In addition to
exchanging the centromere arm, this fragmentation strategy
results in the removal of 320kb proximal to the tyrosinase gene,
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Figure 2. Modification of Tyrl to the amplifiable YAC YRT2. The upper part
of the figure is a map of the tyrosinase gene: solid boxes marked 1 to 5 represent
exons. A 5kb EcoKUBamHI fragment at the 3' end of the tyrosinase gene was
cloned into the long arm of the YAC vector Y-RC16 (13) producing the
fragmentation vector pFRAT3' (middle part of the figure). Transformation of
BamHI linearized pFRAT3' into Tyrl containing yeast cells leads to homologous
recombination and formation of a 250kb YAC, YRT2 (bottom of the figure).
The recombination event is symbolized by the cross. Markers present in vector
arms of the YACs are indicated as described before (13,14). Restriction sites
for Smal on Tyrl are given according to Figure 1.
reducing the YAC from 570 to 250kb, but leaves unaltered the
155kb 5' to the gene, which might contain sequences important
for its full level expression (Figure 2). 5jig BamHI linearized
pFRAT3' DNA was transformed into yeast carrying Tyrl and
recombinant clones were selected for the presence of the
thymidine kinase gene. YAC clones resulting from the desired
recombination event were identified by PFGE analysis of
undigested yeast DNA: 7 out of 30 clones showed a new
chromosomal band of the expected size of 250kb. The relatively
high background of clones not carrying a fragmented YAC could
be explained by recombination of the Trpl genes present on Tyrl
and pFRAT3' or by circularization of the plasmid pFRAT3', the
latter having been observed in a high percentage of unrecombined
clones (data not shown).
Figure 3A shows the PFGE analysis of undigested DNA of
Tyrl and a recombinant clone, YRT2. Running conditions have
been optimized for the separation of fragments around 250kb.
Whilst the 570kb band corresponding to Tyrl migrates just below
the limited mobility DNA (L.M.D.), a band of 250kb can be
readily detected in YRT2 DNA. Hybridization with a probe
specific for tyrosinase (Figure 3B) detects both YAC DNAs,
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Figure 3. PFGE analysis of YAC DNA. A) DNAs (from 1 x 10s cells embedded
in agarose plugs) from yeast strains containing Tyrl (lane 1), YRT2 (lane 2)
and YRT2 after amplification Gane 3), as well as approximately 200 ng of purified
YRT2 YAC DNA (lane 4) were separated by PFGE. The 570kb YAC Tyrl
migrates just below the DNA with limiting mobility (L.M.D.). The modified
YAC, YRT2, can be seen as a band migrating between the two smallest yeast
chromosomes I and VI. B) Autoradiogram of the corresponding Southern blot
hybridized with a tyrosinase cDNA (pmcTyrlO2). Amplification of the YAC is
approximately 25 fold as determined be comparing the hybridization signals of
lanes 2 and 3 (Phosphoimager, Molecular Dynamics). No degradation of the
isolated YRT2 is visible (lane 4).
indicating that the smaller is a bonafide fragmentation product
containing the tyrosinase gene. The structure of YRT2 was
verified by restriction enzyme and hybridization analysis (data
not shown).
Amplification of YACs is achieved by growth in galactose
containing medium, which leads to induction of the galactose
promoter and, consequently, transcription through the
centromere. Amplification in the strain AB138O has been
described (29). However, we were unable to grow YRT2 and
our AB1380 strain on galactose, which suggests that the YAC
library (18) was constructed using a different isolate of AB1380.
Therefore, YRT2 was transformed into the well defined Gal+
strain CGY2516 (ATCC # 74013), a strain which has previously
been used for amplification (13,15). A 25 fold amplification of
YRT2 was observed, as determined by comparison of the
hybridization signals of a tyrosinase specific probe to DNA
prepared from an equivalent number of cells before and after
amplification (Figure 3B, lanes 2 and 3).
To obtain pure and highly concentrated YAC DNA suitable
for microinjection, a simple two step gel purification procedure
was devised (for details see material and methods). Firstly, the
YAC was separated from the endogenous yeast chromosomes
on a preparative pulsed field gel. A second gel run into 4% LMP
agarose was performed to increase the DNA concentration within
the gel slice up to four fold. The agarose slice was equilibrated
in a buffer containing polyamines with NaCl (Table I), in order
to stabilize the YAC DNA (18,30). DNA was liberated by
digestion with agarase and purified by dialysis against a buffer
containing NaCl and/or polyamines. The concentration of DNA
routinely recovered by this procedure was conservatively
estimated to be between 4 and 20ng/ml and, therefore, clearly
represents an improvement on other methods (9-12).
Before microinjection, an aliquot of the DNA preparation was




































































 P = 10 mM Tris:HCl ph7.5, 0.1 mM EDTA, 30 pM spermine, 70 fiM
spermidine P/Na = P + 100 mM NaCl
* Initial DNA concentration (see text)
* The number of oocytes transferred to foster mothers which became pregnant
free of contamination with endogenous yeast chromosomes
(Figure 3 A, lane 4). Moreover, no sign of degradation could be
detected, either upon ethidium bromide staining or after
hybridization with a tyrosinase specific probe (Figure 3B, lane
4). Although isolation of DNA from single copy YACs is possible
(12; A.S., unpublished results), DNA solutions obtained from
yeast after amplification are several times more concentrated.
Furthermore, preparations from unamplified YACs are more
highly contaminated with endogenous yeast chromosomes and
smaller, degraded DNA. These contaminants are likely to result
from DNA being trapped and only slowly released from high
density plugs which, therefore, comigrates with the YAC band.
Recently, a method was described in which isolated YAC DNA
was concentrated by centrifugation in filter units (12). Our
previous trials with similar methods proved unsatisfactory,
however, which might be due to differences in the purification
protocols or buffers employed.
Microinjection of YAC DNA into fertilized mouse oocytes
Table I summarizes microinjection experiments performed with
five independent DNA preparations. In experiments with
preparations 1 to 3, which were dialysed against a microinjection
buffer lacking NaCl, very few transgenic mice were obtained.
The combination of low ionic strength and polyamines was
suspected to lead to precipitation of the DNA during storage.
Indeed, small particles were observed passing through the
microinjection needle with these preparations. This suspicion was
confirmed in tests in which X DNA in the presence of varying
concentrations of NaCl and polyamines was subject to
centrifugation (data not shown). Similar to results shown in ref.
12, we found that DNA was precipitated by centrifugation in
solutions containing as little as 100/tM polyamines, unless NaCl
was present at >50mM. Therefore, a microinjection buffer was
chosen which contained 30/tM spermine, 70/iM spermidine and
lOOmM NaCl in lOmM Tris:HCl, O.lmM EDTA (pH7.5), in
which DNA remained in solution for long periods without
degradation. A much higher frequency of transgenic mice
amongst live born mice was obtained with DNA microinjected
in this buffer (Table I).
NMRI fertilized oocytes were microinjected and kept at 37 °C
in a CO2 incubator for periods between a few hours and
overnight. The survival of oocytes at this stage (50—75%) was
comparable to that obtained with conventional DNA preparations
(DNA at 4ng/ml in lOmM Tris, pH7.5, O.lmM EDTA; L.M.,
unpublished results). Of the oocytes microinjected with the DNA
preparations in the optimized microinjection buffer (4 and 5),
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393 were transferred to 12 pseudopregnant NMRI females. Seven
of these females, which had received a total of 240 oocytes, gave
birth to 24 mice, of which 5 (21 %) were identified as transgenic
by pigmentation and DNA analysis (Table I). This frequency is
comparable to the efficiency of transgenesis with conventional
constructs (31). The number of pups obtained from the oocytes
which had received YAC DNA in our optimized microinjection
buffer (batches 4 and 5) was somewhat lower than expected (24
pups from 240 oocytes). However, this was compensated by the
high frequency of transgenic offspring (5 out of 24). An
explanation for this slight reduction could be the relatively high
DNA concentrations of these preparations (estimated to be
5ng/ml), since DNA solutions greater than 5ng/ml have been
shown to reduce the overall efficiency of transgenesis (31).
The ability to prepare pure YAC DNA at high concentration
should benefit other methods, such as the lipofection of YAC
DNA into ES cells (10,11) and the microinjection of somatic cells
(12). The recovery of ES clones with integrated YAC DNA has
been plagued by problems of low efficiency, which might be due,
in part, to the limiting amounts of YAC DNA used. In addition,
the majority of ES and somatic cells into which YAC DNA has
been lipofected were shown to contain incomplete copies of the
YAC DNA (10-12). This implies that lipofection may suffer
from a size limitation, and suggests that microinjection will be
the method of choice for larger molecules (12,14).
In a previous report (14) we described the generation of YAC
transgenic mice with YRT2 DNA isolated by the method
presented above. Mice from four out of the five transgenic lines
analysed contained integrated copies of both vector arms,
suggesting that the YAC DNA had remained intact during
microinjection (Table I). Transfer of a 230kb YAC by
microinjection has been achieved in somatic cells: complete copies
of the YAC DNA were integrated in 7 out of 10 clones (12).
In contrast, a 590kb construct was not transferred intact. It was
speculated that the microinjection needle might impose a size limit
on the passage of the YAC DNA. Polyamines were not included
in that experiment (12), since they were shown to be dispensible
for maintaining the integrity of the YAC DNA in solutions of
high ionic strength (lOOmM NaCl). Polyamines precipitate DNA
in buffers of low ionic strength as a result of intra- and
intermolecular bridges between the positively charged polyamines
and the negatively charged DNA (32,33). Electronmicroscopy
studies show that globular structures form upon polyamine
treatment of DNA (33). If it were possible to adjust the ionic
strength and polyamine concentration to allow formation of
compact globular structures without precipitation of DNA,
microinjection of molecules well in excess of 250kb could be
possible. At the moment, we do not know whether our buffer
conditions fulfill this requirement. Further microinjection
experiments as well as electromicroscopic investigations of DNA
in various buffers will show whether it is feasible to microinject
larger YAC constructs. Because tyrosinase expression is such
an easy phenotypic marker, our tyosinase YACs, the largest of
which is 850kb, provide an ideal resource with which to pursue
these experiments.
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